BAM
DRNA

Blueshift Asset Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Blueshift Asset Management’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5,585
Closed -$208K – 1383
2021
Q2 		$208K Buy
+5,585
New +$208K 0.01% 838